The medtech industry continues to face several headwinds. The buyer center is changing. Providers are consolidating. There’s an increased focus on value and business model disruption. Medtech faces some existential questions, forcing it to find new ways to stoke growth and stem profit erosion. Our stance has always been that, in addition to revamping its business strategy, medtech needs to become analytically-driven. Medtech companies must leverage their data and analytics to optimize their business strategies and enable growth in ways that are consistent, continuous and agile.
Read MoreBy using this site, you are consenting to the use of cookies on your device. For details, please view our privacy policy.